 Connection
Alexander Kaizer to Research Design
This is a "connection" page, showing publications Alexander Kaizer has written about Research Design.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.023 |
|
|
|
-
Wild JL, Ginde AA, Lindsell CJ, Kaizer AM. Upstrapping to determine futility: predicting future outcomes nonparametrically from past data. Trials. 2024 May 09; 25(1):312.
Score: 0.581
-
Kaizer AM, Koopmeiners JS, Chen N, Hobbs BP. Statistical design considerations for trials that study multiple indications. Stat Methods Med Res. 2021 03; 30(3):785-798.
Score: 0.458
-
Kaizer A, Kittelson J. Discussion on "Predictively Consistent Prior Effective Sample Sizes" by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan. Biometrics. 2020 06; 76(2):588-590.
Score: 0.438
-
Kaizer A, Zabor E, Nie L, Hobbs B. Bayesian and frequentist approaches to sequential monitoring for futility in oncology basket trials: A comparison of Simon's two-stage design and Bayesian predictive probability monitoring with information sharing across baskets. PLoS One. 2022; 17(8):e0272367.
Score: 0.128
-
Ling SX, Hobbs BP, Kaizer AM, Koopmeiners JS. Calibrated dynamic borrowing using capping priors. J Biopharm Stat. 2021 11 02; 31(6):852-867.
Score: 0.122
-
Zabor EC, Kaizer AM, Hobbs BP. Randomized Controlled Trials. Chest. 2020 07; 158(1S):S79-S87.
Score: 0.111
-
Kaizer AM, Hobbs BP, Koopmeiners JS. A multi-source adaptive platform design for testing sequential combinatorial therapeutic strategies. Biometrics. 2018 09; 74(3):1082-1094.
Score: 0.094
-
Kammer MN, Rowe DJ, Deppen SA, Grogan EL, Kaizer AM, Bar?n AE, Maldonado F. The Intervention Probability Curve: Modeling the Practical Application of Threshold-Guided Decision-Making, Evaluated in Lung, Prostate, and Ovarian Cancers. Cancer Epidemiol Biomarkers Prev. 2022 09 02; 31(9):1752-1759.
Score: 0.032
-
Hobbs BP, Pestana RC, Zabor EC, Kaizer AM, Hong DS. Basket Trials: Review of Current Practice and Innovations for Future Trials. J Clin Oncol. 2022 10 20; 40(30):3520-3528.
Score: 0.032
-
Chen AH, Harmatz P, Nestrasil I, Eisengart JB, King KE, Rudser K, Kaizer AM, Svatkova A, Wakumoto A, Le SQ, Madden J, Young S, Zhang H, Polgreen LE, Dickson PI. Intrathecal enzyme replacement for cognitive decline in mucopolysaccharidosis type I, a randomized, open-label, controlled pilot study. Mol Genet Metab. 2020 02; 129(2):80-90.
Score: 0.027
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|